Get the latest protea biosciences group stock price and detailed information including news, historical charts and realtime prices. Protea is a leader in the emerging field of bioanalytics. Stock analysis for protea biosciences group inc prgbd including stock price, stock chart, company news, key statistics, fundamentals and company profile. Macroaxis derives these conditions on a daily bases from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns including short term and long term historical volatility. Protea is an emerging growth, molecular information company that has developed what we believe is a revolutionary platform technology which enables the direct analysis, mapping and display of.
Ondemand data for mobile applications with json and xml support in an easy to use format. Prgb protea announced today that it has expanded its clinical research study for its new molecular. The company develops new technology for the identification, characterization, and quantitation of biologicallyimportant molecules for. It is engaged in developing and commercializing proprietary life science technologies, products, and services that are used to identify the molecules that are produced by living cells and all life forms. Johns university and is a registered pharmacist in new jersey and california. Using stateoftheart instrumentation including high resolution, accurate mass hram mass spectrometry systems, maldi, and the laesi dp direct ionization system. Protea biosciences groups revenues are gauged from an analysis of company filings. Get breaking news and analysis on protea biosciences group inc prgb stock, price quote and chart, trading and investing tools. Filed by christopher schueller on behalf of protea biosciences, inc.
Filed by christopher schueller on behalf of protea biosciences, inc attachments. Protea biosciences, based in morgantown, wv, is a leader in the development of new protein separation and identification technology. Prgb files an 8k termination of a material definitive agreementitem 1. All forwardlooking statements included in this press release are made. Any exhibits should be sent as separate attachments, not a combined pdf.
Agilent technologies inc, protea biosciences group inc. Cna finance initiates research coverage on protea biosciences. Proteas mass spec grade protein standards are for use in mass spectrometry, molecular biology, and life science laboratories. Analyze up to 10 years of full 10k annual reports and quarterly 10q sec filings for protea biosciences group, inc. Streamlined access to financial data and information, extracted from sec filings. This page shows recent sec filings related to protea biosciences group inc. The intellectual property of protea biosciences group includes 2 registered patents primarily in the testing category. Maged currently serves as an independent director for protea biosciences and azurrx biopharma. Company bankruptcy information for protea biosciences, inc. Laesi ms imaging and lcms global metabolomics of plant metabolites of sorghum bicolor grown in association with symbiotic fungi. Protea biosciences expands clinical study for new melanoma. All forwardlooking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to. Protea is a technology leader in the field of mass spectrometry mass spec molecular imaging the identification and localization of the molecular products of all living cells.
United states of america before the securities and. Latest sec filings for protea biosciences group inc prgb. Protea announces research agreement with mass general hospital. Protea biosciences group inc is a bioanalytics technology company based in the united states. These reports include company annual reports 10k, 10q, news updates 8k, investor presentations found in 8ks, insider trades form 4, ownership reports d, and g, and reports related to the specific securities sold, such as registration statements and prospectus. Configurable data packages, ensuring partners receive the specific data they need. Information provided is not approved by the institution itself. Protea biosciences group inc prgb sec filings seeking.
Provided below are links to security agreements with virginia governing law clauses. Launches new tissue analytics software and workflow read this article along with other careers information, tips and advice on biospace. Filed by christopher schueller on behalf of protea biosciences group, inc. Briefprotea biosciences group says board determined it. Governing law state of virginia agreements, contracts. Are you researching protea biosciences group otcmkts. By enabling researchers to better identify protein biomarkers in blood samples, proteas technology cuttingedge, proteomics research work helps biotechnology and pharmaceutical research companies develop improved drug therapies for cancer and other. Governing law provisions also knows as choice of law or controlling law clauses in contracts are frequently used by the agreement parties to specify which jurisdictions laws will be applied to interpreting the contractual provisions and obligations.
Emergency motion for joint administration of these bankruptcy cases for procedural purposes with certificate of service. A method of differentiating benign melanocytic nevi from malignant melanomas is disclosed. Coral springs, fl prweb august 09, 2017 cna finance initiates research coverage on protea biosciences. Annual report on protea biosciences groups revenue. United states securities and exchange commission washington, d. Prgb protea announced today that it has expanded its clinical research study for its new molecular imaging test for the differential diagnosis of malignant melanoma. Briefprotea biosciences files for common stock offering. Information provided on this web page is aggregated encyclopedic and bibliographical information relating to the named institution. These investors may include private investors, venture capital firms, or other investment vehicles. About protea biosciences group, inc protea biosciences group, inc. Johns university and is a registered pharmacist in new jersey. I have been working at protea biosciences fulltime for less than a year.
Prgb files an 8k unregistered sales of equity securities item 3. Briefprotea biosciences group says board determined it will be required to file voluntary petition for reorganization under chapter 11. Protea announces research agreement with mass general hospital developing molecular tests to help guide tumor immunotherapy. Visit our resource center to learn more about our technologies and capabilities learn more. Improved documentation and sample calls for faster and easy onboarding.
Protea september 6, 20 press highlights world molecular imaging congress savannah, ga, september 18 21, 20. Additionally, protea biosciences group has registered 3 trademarks with the most popular class being scientific and electric apparatus and instruments. Find the latest sec filings data for protea biosciences group prgbq at. Protea expands clinical study for new melanoma test.
Product information document bsa bovine serum albumin catalog number. The registered agent on file for this company is corporation service company and is located at 209 west washington street, charleston, wv 25302. Protea announces research agreement with mass general. See insights on protea biosciences group including office locations, competitors, revenue, financials, executives, subsidiaries and more at craft. Prgb sec filings, 10k, 8k protea biosciences group inc. The method generally includes subjecting a skin lesion sample from a patient to mass. Protea biosciences opens new demonstration and training. Protea biosciences is an innovative bioanalytics technology organization offering mass spectrometry imaging and lcms services focused on protein characterization, proteomics, metabolomics, and small molecule analysis. Article stock quotes 1 comments 2 free breaking news alerts from. Investor activity protea biosciences group has actively raised capital from investors.
345 1050 924 1385 64 790 191 266 96 956 1387 908 238 1177 1462 1133 1008 695 232 659 1112 911 658 177 1197 1357 891 158 745 817 1066 182 1331 827 846 700